ArticlemedRxiv : the preprint server for health sciences2026
ADHD symptom trajectories and brain morphometry: A longitudinal analysis.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Objective: While ADHD symptoms often decline from childhood into adulthood, the underlying neurobiological mechanisms, such as altered brain maturation or neural reorganization, remain incompletely understood. This study investigated how grey matter development relates to ADHD symptom trajectories into adulthood. Method: We analyzed data of individuals with ADHD and controls from the longitudinal Dutch NeuroIMAGE cohort, utilizing dimensional ADHD symptom scores (Conners Parent Rating Scale) from three waves and T1-weighted structural MRI scans from the final two waves. Using General Linear Models with permutation-based inference, we examined: 1) cross-sectional associations between ADHD symptoms and vertex-wise cortical thickness and surface area, and subcortical volumes at Wave 1 (n=765, mean age =16.95 years); and 2) longitudinal associations between symptom progression and brain morphometric changes (Wave 0 to 1: n=644, mean age=11.55-17.24 years; Wave 1 to 2: n=149, mean age=16.45-20.11 years). Results: Cross-sectionally, at Wave 1, more ADHD symptoms were related to widespread reductions in surface area, most prominently in the frontal cortex, and smaller volumes of the cerebellum, amygdala, and hippocampus. Longitudinally, symptom improvement from Wave 1 to Wave 2 was associated with stronger reductions in surface area, particularly in prefrontal and occipital regions, and with more pronounced cortical thinning across multiple brain regions. Conclusion: These findings suggest an association between symptom trajectories and structural brain changes, indicating that clinical improvement in ADHD behaviors might coincide with ongoing neural refinement during the transition to adulthood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.